Long-term follow-up of the SBG 9401 study comparing tailored FEC-based therapy versus marrow-supported high-dose therapy.
Wilking N, Lidbrink E, Wiklund T, Erikstein B, Lindman H, Malmström P, Kellokumpu-Lehtinen P, Bengtsson NO, Söderlund G, Anker G, Wist E, Ottosson S, Salminen E, Ljungman P, Holte H, Nilsson J, Blomqvist C, Bergh J.
Wilking N, et al. Among authors: nilsson j.
Ann Oncol. 2007 Apr;18(4):694-700. doi: 10.1093/annonc/mdl488. Epub 2007 Feb 13.
Ann Oncol. 2007.
PMID: 17301072
Free article.
Clinical Trial.